STAT3 and central nervous system cancer: Napabucasin is another recently characterized orally bioavailable small-molecule STAT3 inhibitor capable of inducing cell cycle arrest, apoptosis, and the reduction of markers of stemness, leading to improved survival in an orthotopic murine glioma model [242,243].